Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors

American Journal of Neuroradiology

Volumn 23, Issue 4, 2002, Pages 510-519

  Varallyay, Peter ^a   Nesbit, Gary ^a   Muldoon, Leslie L ^a   Nixon, Randal R ^a   Delashaw, Johnny ^a   Cohen, James I ^a   Petrillo, Annie ^a   Rink, Doris ^a   Neuwelt, Edward A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM CHELATE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; VIRUS VECTOR;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; GLIOBLASTOMA; GLIOMA; HAMARTOMA; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS ADENOMA; INTERMETHOD COMPARISON; INTRACRANIAL TUMOR; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; GENETIC VECTORS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; PARTICLE SIZE; VIRUSES;

EID: 0036120171     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Detection of liver metastasis: Comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US
2. Hepatic MR with SPIO: Detection and characterization of focal liver lesions
3. MRI in focal liver disease: A comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents
4. Multicenter dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging
5. Superparamagnetic iron oxide: Enhanced detection of focal splenic tumors with MR imaging
6. MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): Preliminary observations
7. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evalution of mediastinal lymph nodes in patients with primary lung carcinoma
8. Functional magnetic resonance imaging using iron oxide particles in characterizing head and neck adenopathy
9. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography
10. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent
11. Superparamegetic agents in magnetic resonance imaging: Physicochemical characterisitics and clinical applications: A review
12. Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION-46L enhanced in vivo MRI: Early histopathological correlation
13. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance
14. Comparison of ultrasmall particles of iron oxide (USPIO) -enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced TI-weighted MR images in rats with experimental autoimmmune encephalomyelitis
15. Delivery of virus-sized iron-oxide particles to rodent CNS neurons
16. A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery
17. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent
18. Can superparamagnetic contrast media improve MRI-tomographic images of experimental gliomas?
19. MR imaging of phagocytosis in experimental gliomas
20. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model
21. Magnetically labeled cells can be detected by MR imaging
22. Increasing volume of distribution to brain with interstitial infusion: Dose, rather than convection, may be the most important factor
23. MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: The potential for noninvasive diagnosis
24. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsil
25. Outwitting the blood-brain barrier for therapeutic purposes: Osmotic opening and other means
26. Association of total dose intensity of chemotherapy in primary CNS lymphoma (human non-AIDS) and survival
27. Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat
28. Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery
29. New MRI contrast agent for labeling of tumor-associated macrophages that stimulate tumor angiogenesis
30. Monocrystalline iron oxide nanoparticles: Possible solution to the problem of surgically induced intracranial contrast enhancement in intraoperative MR imaging
31. Comparison of intracerbral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus and iron oxide particles to normal rat brain